FDA Inspection 711197 — K.C. Pharmaceuticals, Inc

K.C. Pharmaceuticals, Inc — FEI 2026940

The FDA completed an inspection of K.C. Pharmaceuticals, Inc on February 14, 2011 in Pomona, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 11 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 14, 2011
Fiscal Year
2011
Product Type
Devices
Project Area
Compliance: Devices
Location
Pomona, CA (United States)

Citations

IDCFRDescription
108621 CFR 211.22(b)Adequate lab facilities not available
110521 CFR 211.22(d)Procedures not in writing, fully followed
111121 CFR 211.25(a)Training , Education , Experience overall
117721 CFR 211.63Equipment Design, Size and Location
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
185121 CFR 211.84(e)Rejecting When Specifications Not Met
192021 CFR 211.166(a)(3)Valid stability test methods
202721 CFR 211.192Investigations of discrepancies, failures
313021 CFR 820.100(a)Lack of or inadequate procedures
363221 CFR 211.170(b)Annual visual exams of drug products
73121 CFR 803.50(a)(1)Report of Death or Serious Injury